TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -276.22%-92.71M | ---- | 80.32%-24.64M | ---- | -293.37%-125.18M | ---- | -178.15%-31.82M | ---- | -145.29%-11.44M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 54.79%-2.36M | ---- | -580.68%-5.21M | ---- | -1.06%-766K | ---- | 48.99%-758K | ---- | 60.09%-1.49M |
Impairment and provisions: | ---- | 642.34%68.7M | ---- | -47.74%9.25M | ---- | -17.49%17.71M | ---- | 18,892.92%21.46M | ---- | -82.64%113K |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | -69.85%5.04M | ---- | --16.7M | ---- | ---- |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | --5.67M | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | 642.34%68.7M | ---- | 32.16%9.25M | ---- | 47.16%7M | ---- | 4,110.62%4.76M | ---- | -82.64%113K |
Revaluation surplus: | ---- | -92.14%382K | ---- | -23.31%4.86M | ---- | 1,197.06%6.34M | ---- | -107.71%-578K | ---- | --7.5M |
-Other fair value changes | ---- | -92.14%382K | ---- | -23.31%4.86M | ---- | 1,197.06%6.34M | ---- | -107.71%-578K | ---- | --7.5M |
Asset sale loss (gain): | ---- | 108.10%383K | ---- | -666.35%-4.73M | ---- | 16,600.00%835K | ---- | -50.00%5K | ---- | -71.43%10K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---5.06M | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 17.13%383K | ---- | -60.84%327K | ---- | 16,600.00%835K | ---- | -50.00%5K | ---- | -71.43%10K |
Depreciation and amortization: | ---- | -5.01%5.08M | ---- | -18.31%5.34M | ---- | -3.45%6.54M | ---- | -3.34%6.78M | ---- | -1.38%7.01M |
-Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | 0.00%197K | ---- | 64.17%197K | ---- | --120K |
Financial expense | ---- | -22.99%3.05M | ---- | 2.41%3.95M | ---- | 4.61%3.86M | ---- | -66.84%3.69M | ---- | 5.89%11.13M |
Special items | ---- | ---- | ---- | -0.43%4.42M | ---- | 147.10%4.44M | ---- | -54.69%1.8M | ---- | 423.86%3.96M |
Operating profit before the change of operating capital | ---- | -158.96%-17.48M | ---- | 92.17%-6.75M | ---- | -15,200.35%-86.22M | ---- | -96.60%571K | ---- | -56.50%16.8M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 308.19%16.9M | ---- | -106.14%-8.12M | ---- | 3,615.96%132.17M | ---- | 96.04%-3.76M | ---- | -316.97%-94.89M |
Accounts receivable (increase)decrease | ---- | 63.32%-18.81M | ---- | 27.91%-51.27M | ---- | -154.74%-71.12M | ---- | 95.51%129.92M | ---- | 181.68%66.45M |
Accounts payable increase (decrease) | ---- | -98.18%1.21M | ---- | 319.54%66.46M | ---- | -276.60%-30.27M | ---- | 383.39%17.14M | ---- | 82.74%-6.05M |
prepayments (increase)decrease | ---- | 135.49%13.59M | ---- | -1,806.37%-38.28M | ---- | -113.09%-2.01M | ---- | -54.45%15.34M | ---- | 187.24%33.67M |
Financial assets at fair value (increase)decrease | ---- | -33.31%-3.78M | ---- | 40.17%-2.84M | ---- | ---4.74M | ---- | ---- | ---- | ---- |
Cash from business operations | ---- | 79.48%-8.37M | ---- | 34.41%-40.8M | ---- | -139.07%-62.2M | ---- | 896.43%159.21M | ---- | 122.00%15.98M |
China income tax paid | ---- | 83.49%-727K | ---- | -179.80%-4.4M | ---- | 51.94%-1.57M | ---- | 50.58%-3.28M | ---- | -77.76%-6.63M |
Special items of business | -220.68%-28.53M | ---- | 39.13%-8.9M | ---- | 78.94%-14.62M | ---- | -140.49%-69.41M | ---- | 815.31%171.45M | ---- |
Net cash from operations | -220.68%-28.53M | 79.87%-9.1M | 39.13%-8.9M | 29.13%-45.2M | 78.94%-14.62M | -140.90%-63.77M | -140.49%-69.41M | 1,567.56%155.93M | 815.31%171.45M | 112.24%9.35M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -72.73%1.31M | ---- | 526.24%4.8M | ---- | 1.06%766K | ---- | -48.99%758K | ---- | 151.01%1.49M |
Loan receivable (increase) decrease | ---- | 110.12%1.26M | ---- | ---12.44M | ---- | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | ---- | -95.55%1.53M | ---- | 1,764.59%34.51M | ---- | -78.25%-2.07M | ---- | -158.98%-1.16M | ---- | 105.74%1.97M |
Sale of fixed assets | ---- | ---- | ---- | -7.14%26K | ---- | -93.59%28K | ---- | 4,755.56%437K | ---- | -83.33%9K |
Purchase of fixed assets | ---- | 73.32%-803K | ---- | -212.24%-3.01M | ---- | -7.35%-964K | ---- | -344.55%-898K | ---- | 82.30%-202K |
Sale of subsidiaries | ---- | ---- | ---- | --29.84M | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.77M |
Other items in the investment business | 2,964.63%5.03M | ---- | -98.79%164K | ---21.53M | 352.13%13.58M | ---- | -13.56%-5.39M | ---- | -76.15%-4.74M | ---- |
Net cash from investment operations | 2,964.63%5.03M | -89.76%3.3M | -98.79%164K | 1,535.22%32.19M | 352.13%13.58M | -159.01%-2.24M | -13.56%-5.39M | -276.02%-866K | -76.15%-4.74M | 607.22%492K |
Net cash before financing | -169.15%-23.51M | 55.39%-5.8M | -739.71%-8.73M | 80.30%-13.01M | 98.61%-1.04M | -142.57%-66.02M | -144.87%-74.8M | 1,475.41%155.07M | 939.37%166.7M | 112.87%9.84M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 2.07%73.39M | ---- | -22.10%71.9M | ---- | 19.64%92.3M | ---- | -62.84%77.15M | ---- | -7.15%207.6M |
Refund | ---- | 16.39%-68.1M | ---- | 11.27%-81.45M | ---- | 54.73%-91.8M | ---- | -0.53%-202.8M | ---- | -6.10%-201.73M |
Issuing shares | ---- | ---- | ---- | 208.60%38.41M | ---- | 95.26%12.45M | ---- | --6.38M | ---- | ---- |
Interest paid - financing | ---- | 22.99%-3.05M | ---- | -2.41%-3.95M | ---- | -4.61%-3.86M | ---- | 63.75%-3.69M | ---- | 3.13%-10.18M |
Absorb investment income | ---- | 1,188.24%438K | ---- | -86.97%34K | ---- | -5.09%261K | ---- | --275K | ---- | ---- |
Other items of the financing business | 337.41%21.31M | ---- | -90.80%4.87M | ---- | 43.94%52.93M | ---- | 120.06%36.77M | ---- | -2,484.27%-183.3M | 116.99%2.66M |
Net cash from financing operations | 337.41%21.31M | -89.24%2.68M | -90.80%4.87M | 166.84%24.94M | 43.94%52.93M | 107.62%9.35M | 120.06%36.77M | -7,308.88%-122.69M | -2,484.27%-183.3M | -106.12%-1.66M |
Effect of rate | 189.29%125K | -116.60%-358K | 98.01%-140K | 160.70%2.16M | -29,162.50%-7.02M | 495.69%827K | 97.80%-24K | -134.15%-209K | -276.70%-1.09M | 30,500.00%612K |
Net Cash | 43.06%-2.2M | -126.13%-3.12M | -107.44%-3.86M | 121.06%11.94M | 236.47%51.89M | -275.03%-56.67M | -129.08%-38.02M | 295.47%32.38M | -285.54%-16.6M | 116.57%8.19M |
Begining period cash | -20.98%13.09M | 568.72%16.57M | 568.72%16.57M | -95.75%2.48M | -95.75%2.48M | 123.01%58.32M | 123.01%58.32M | 50.71%26.15M | -60.82%26.15M | -74.01%17.35M |
Cash at the end | -12.32%11.02M | -20.98%13.09M | -73.45%12.57M | 568.72%16.57M | 133.55%47.35M | -95.75%2.48M | 139.59%20.27M | 123.01%58.32M | -88.91%8.46M | 50.71%26.15M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.